| Prostate Cancer: Data, Statistics, and Incentives (Why We Still Lack Answers to Important Questions) SEPTEMBER 27TH, 2022 | 11:00am Pacific (2:00pm Eastern) |
| Examples of some important questions: Is PSA screening for prostate cancer a positive public health measure? What is the value of curative treatment to the individual patient or to the population at risk and how is it best measured? Which of the several treatment variations are the most effective? And does that even matter, given the rapidly changing patterns of practice? The problem is that these are extremely difficult questions to answer. The ‘Why’ is interesting. Join us for this intriguing discussion with:  Dr. William James Morris, BSc, MSc, MD, FRCPC Radiation Oncologist, Vancouver Centre, BCCANCER (retired 2018) Clinical Professor, Faculty of Medicine, UBC |
| Partners in Prostate – Support Group for Partners WEDNESDAY, SEPTEMBER 28TH, 2022 | 6:00pm Pacific (9:00pm Eastern) |
| Advanced Prostate Cancer WEDNESDAY, OCTOBER 12TH | 4:00pm Pacific (7:00pm Eastern) Advanced prostate cancer patients include anyone with cancer that has spread (metastatic), with a castrate-resistant cancer (no longer responds to first-line ADT), or with a high-risk or complex diagnosis. Sign up for the Advanced Prostate Cancer mailing list to ensure you’re informed about upcoming meetings. Register for the October meeting here. |
| Active Surveillance Support Group THURSDAY, OCTOBER 13TH | 4:30pm Pacific (7:30pm Eastern) This group’s goal is to empower men newly diagnosed with low- or intermediate-risk prostate cancer to make informed decisions with their physicians on active surveillance as a non-invasive treatment option. Sign up for the Active Surveillance mailing list to ensure you’re informed about upcoming meetings. Register for the October meeting here. |
| Looking for local prostate cancer support group meetings? Go to the Prostate Cancer Support Canada calendar here. |
